Weekly transdermal donepezil equally effective, more tolerable than daily oral therapy

SAN DIEGO — A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia, per a presenter at the Alzheimer’s Association International Conference.
“Donepezil, a reversible acetylcholinesterase inhibitor, is the most prescribed medication for the treatment of dementia of the Alzheimer’s type in patients with mild, moderate and severe disease,” Pierre N. Tariot, of Banner Alzheimer’s Institute in Phoenix, noted in his poster presentation.
Tariot and fellow researchers

SAN DIEGO — A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia, per a presenter at the Alzheimer’s Association International Conference.
“Donepezil, a reversible acetylcholinesterase inhibitor, is the most prescribed medication for the treatment of dementia of the Alzheimer’s type in patients with mild, moderate and severe disease,” Pierre N. Tariot, of Banner Alzheimer’s Institute in Phoenix, noted in his poster presentation.
Tariot and fellow researchers